Councilmark Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$787K Sell
856
-31
-3% -$31.4K 0.45% 41
2025
Q4
$953K Hold
887
0.53% 38
2025
Q3
$677K Hold
887
0.39% 46
2025
Q2
$691K Hold
887
0.44% 47
2025
Q1
$733K Sell
887
-15
-2% -$12.5K 0.49% 46
2024
Q4
$696K Hold
902
0.47% 45
2024
Q3
$799K Buy
902
+2
+0.2% +$1.8K 0.54% 45
2024
Q2
$815K Hold
900
0.58% 43
2024
Q1
$700K Buy
+900
New +$641K 0.5% 46

Other funds holding LLY

Councilmark Asset Management's LLY Position: Q1 2026 in Review

Councilmark Asset Management reduced its Eli Lilly (LLY) stake by 3.5% in Q1 2026, selling an estimated $31.4K and leaving 856 shares worth $787K. The position accounts for 0.45% of the portfolio, ranked #41.

Councilmark Asset Management first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $953K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Councilmark Asset Management held 856 shares of Eli Lilly worth $787K as of Q1 2026.
  • Councilmark Asset Management sold 31 Eli Lilly shares in Q1 2026, an estimated $31.4K.
  • Eli Lilly made up 0.45% of Councilmark Asset Management's portfolio in Q1 2026, its #41 holding.
  • Councilmark Asset Management first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • Councilmark Asset Management's Eli Lilly position peaked at $953K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Councilmark Asset Management's 13F filing for Q1 2026, filed 12 May 2026.